
Sign up to save your podcasts
Or


How should our neurology clinics be fully prepared to integrate amyloid-targeting therapies (ATTs) into everyday, real-world practice?
Credit available for this activity expires: 10/26/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/european-alzheimers-care-live-case-based-forum-amyloid-2026a1001215?ecd=bdc_podcast_libsyn_mscpedu
Using real-world patient case examples, hear from expert faculty on how they would navigate treatment choices using the latest data for patients with ATTR-CM.
Credit available for this activity expires: 10/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/deciphering-clinical-data-transthyretin-cardiac-amyloidosis-2026a100110n?ecd=bdc_podcast_libsyn_mscpedu
A molecular clock is ticking in your patients with metastatic breast cancer. Are you listening?
Credit available for this activity expires: 10/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-2026a10010phecd=bdc_podcast_libsyn_mscpedu
Discover how novel therapies and expert consensus on the KDIGO framework are revolutionizing IgAN management to slow disease progression.
Credit available for this activity expires: 10/13/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-iga-nephropathy-management-evolving-treatment-2026a10010le?ecd=bdc_podcast_libsyn_mscpedu
ADCs are moving from the metastatic setting into curative-intent neoadjuvant and adjuvant lines of treatment. Are you ready?
Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/antibody-drug-conjugate-therapy-early-breast-cancer-2026a10010lp?ecd=bdc_podcast_libsyn_mscpedu
Do you know who to test, when to test, and which biomarker test to use?
Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/solving-alzheimers-disease-biomarker-puzzle-live-european-2026a1000y9g?ecd=bdc_podcast_libsyn_mscpedu
Do you know how to meet the challenges of treating uveitic macular edema?
Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-uveitic-macular-edema-management-whats-new-2026a1000y92?ecd=bdc_podcast_libsyn_mscpedu
Move beyond supportive care with targeted therapies for immunoglobulin A nephropathy (IgAN) management.
Credit available for this activity expires: 09/24/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journeys-iga-nephropathy-optimizing-outcomes-patient-2026a1000xq5?ecd=bdc_podcast_libsyn_mscpedu
How can adjuvant therapy be optimally individualized? What tools and insights are required? Join us to learn more.
Credit available for this activity expires: 09/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/refining-adjuvant-therapy-hr-positive-her2-negative-early-2026a1000ysl?ecd=bdc_podcast_libsyn_mscpedu
Can CAR T-cell therapies achieve drug-free remission in severe refractory autoimmune diseases?
Credit available for this activity expires: 9/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journey-severe-refractory-autoimmune-rheumatic-2026a1000xbu?ecd=bdc_podcast_libsyn_mscpedu
From the publisher's feed

1,263 Listeners

318 Listeners

499 Listeners

294 Listeners

1,390 Listeners

142 Listeners

891 Listeners

13 Listeners

16 Listeners

291 Listeners

3,337 Listeners

7,911 Listeners

196 Listeners

515 Listeners

367 Listeners

60 Listeners

26 Listeners

432 Listeners